The study discovered new treatments that can assist patients with multiple myeloma, a blood cancer, who have tried the immunotherapy CAR-T but have experienced relapses.
Researchers have identified therapies that can help patients with multiple myeloma blood cancer who try an immunotherapy known as CAR-T only to find their cancer returning afterwards.
Pittsburgh (Pennsylvania) [US], September 15 (ANI): Despite some relapses from the high levels of recovery seen in the years immediately following surgery, improvements in pain, physical function, and work productivity last for at least seven years.